v3.25.2
Summary of Significant Accounting Policies -Disaggregated By Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disaggregation of Revenue [Line Items]        
Total revenue $ 232,088 $ 177,235 $ 435,559 $ 345,726
Oncology        
Disaggregation of Revenue [Line Items]        
Total revenue 158,685 130,269 309,244 256,017
Biopharma and data        
Disaggregation of Revenue [Line Items]        
Total revenue 56,020 43,933 101,396 81,520
Screening        
Disaggregation of Revenue [Line Items]        
Total revenue 14,814 0 20,491 0
Licensing and other        
Disaggregation of Revenue [Line Items]        
Total revenue $ 2,569 $ 3,033 $ 4,428 $ 8,189